Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Aquestive Therapeutics Inc shares valued at $214 were sold by Jung Cassie on Nov 26 ’24. At $4.87 per share, Jung Cassie sold 44 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Schobel Alexander Mark sold 50,000 shares, netting a total of over 300,000 in proceeds. Following the sale of shares at $6.00 each, the insider now holds 984,476 shares.
Before that, Schobel Alexander Mark had sold 25,000 shares from its account. In a trade valued at $129,685, the Chief Innovation/Tech Officer traded Aquestive Therapeutics Inc shares for $5.19 each. Upon closing the transaction, the insider’s holdings decreased to 25,000 shares, worth approximately $3.84 million.
As published in their initiating research note from Leerink Partners on May 10, 2024, Aquestive Therapeutics Inc [AQST] has been an Outperform and the price target has been revised to $8. Analysts at Piper Sandler started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid April. As of March 28, 2024, Raymond James has initiated its “an Outperform” rating for AQST.
Analyzing AQST Stock Performance
During the last five days, there has been a drop of approximately -14.58%. Over the course of the year, Aquestive Therapeutics Inc shares have jumped approximately 82.67%. Shares of the company reached a 52-week high of $6.23 on 03/18/24 and a 52-week low of $1.95 on 01/02/24. A 50-day SMA is recorded $4.85, while a 200-day SMA reached $4.05. Nevertheless, trading volume fell to 0.94 million shares from 1.52 million shares the previous day.
Support And Resistance Levels for Aquestive Therapeutics Inc (AQST)
According to the 24-hour chart, there is a support level at 3.63, which, if violated, would cause prices to drop to 3.57. In the upper region, resistance lies at 3.80. The next price resistance is at 3.90. RSI (Relative Strength Index) is 29.73 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.63, which suggests the price will decrease in the coming days. Percent R is at 99.38%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
